Search - tctmd.com

Displaying 161 - 180 of 213

Sort: Relevancy | Date

News Industry News

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

March 15, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

Presentation TCT 2014

The Five Multislice CT Essentials for Optimal TAVR

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Jonathon A. Leipsic

September 14, 2014

Presentation TCT 2014

The Five Echocardiographic Essentials for Optimal TAVR

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Rebecca T. Hahn

September 14, 2014

Presentation TCT 2014

Multi-device Patient-Specific TAVR Now or in the Future?

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Raj Makkar

September 14, 2014

Presentation TCT 2014

Lessons From the CHOICE Trial

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Mohamed Abdel-Wahab

September 14, 2014

Presentation TCT 2014

Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, John G. Webb

September 14, 2014

Presentation TCT 2014

Special Attributes and Disadvantages of the Self-Expanding TAVR Platform

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Nicolo Piazza

September 14, 2014

Presentation TCT 2014

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Michael J. Reardon

September 14, 2014

Presentation TVT 2014

Lessons Learned about Frailty and Comorbidities from the US CoreValve Trials

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Direct Aortic is Clearly Superior to Transapical!

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Lotus - Status of the US Clinical Trial and Case Examples

Presenter: Ted E. Feldman, Michael J. Reardon

June 06, 2014

Presentation TVT 2014

The High-Risk Randomized Trial

Presenter: Michael J. Reardon

June 05, 2014

News Industry News

Medtronic Reveals Positive Outcomes for CoreValve® Patients Treated via Alternative Access Routes

April 29, 2014

Presentation TCT 2013

Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study

Presenter: Michael Reardon

October 29, 2013

Presentation TCT 2013

My Most Valuable TAVR Lessons: A Surgeon's Perspective

Presenter: Michael Reardon

October 29, 2013

Presentation TCT 2013

New (Open) Surgical Approaches to Aortic Valve Disease

Presenter: Michael Reardon

October 27, 2013

Presentation TCT 2013

Direct Aortic Access is the Preferred (Non-transfemoral) Alternative

Presenter: Michael Reardon

October 27, 2013

Advertisement

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

The Five Multislice CT Essentials for Optimal TAVR

The Five Echocardiographic Essentials for Optimal TAVR

Multi-device Patient-Specific TAVR Now or in the Future?

Lessons From the CHOICE Trial

Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform

Special Attributes and Disadvantages of the Self-Expanding TAVR Platform

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Lessons Learned about Frailty and Comorbidities from the US CoreValve Trials

Direct Aortic is Clearly Superior to Transapical!

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Lotus - Status of the US Clinical Trial and Case Examples

The High-Risk Randomized Trial

Medtronic Reveals Positive Outcomes for CoreValve® Patients Treated via Alternative Access Routes

Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study

My Most Valuable TAVR Lessons: A Surgeon's Perspective

New (Open) Surgical Approaches to Aortic Valve Disease

Direct Aortic Access is the Preferred (Non-transfemoral) Alternative

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content